KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Mar 27, 2019 $136.71 $137.50 $133.10 $134.60 1 106 432
Mar 26, 2019 $133.15 $136.95 $132.61 $136.79 1 737 728
Mar 25, 2019 $130.29 $132.34 $128.30 $132.29 1 684 001
Mar 22, 2019 $133.86 $134.90 $130.10 $130.21 1 512 041
Mar 21, 2019 $130.47 $134.56 $130.03 $134.21 1 729 770
Mar 20, 2019 $133.20 $133.56 $130.85 $131.66 1 702 945
Mar 19, 2019 $133.57 $134.56 $132.39 $132.94 1 005 729
Mar 18, 2019 $136.04 $136.39 $132.86 $133.51 1 744 496
Mar 15, 2019 $135.31 $136.65 $134.62 $136.09 2 070 737
Mar 14, 2019 $135.87 $136.38 $133.48 $134.88 1 361 377
Mar 13, 2019 $135.22 $136.96 $134.48 $135.71 1 066 753
Mar 12, 2019 $132.55 $134.87 $131.79 $134.30 1 560 978
Mar 11, 2019 $128.97 $132.20 $128.35 $132.04 1 306 377
Mar 08, 2019 $127.26 $128.77 $125.70 $128.68 1 194 344
Mar 07, 2019 $131.18 $131.20 $126.71 $128.17 1 667 303
Mar 06, 2019 $134.57 $134.90 $130.60 $131.12 1 241 863
Mar 05, 2019 $136.15 $136.50 $134.26 $134.77 1 030 273
Mar 04, 2019 $138.00 $138.32 $133.39 $136.08 1 502 223
Mar 01, 2019 $132.89 $137.80 $132.66 $137.75 1 445 884
Feb 28, 2019 $135.58 $137.30 $134.37 $135.33 1 556 101
Feb 27, 2019 $132.49 $136.19 $132.00 $136.01 1 131 456
Feb 26, 2019 $131.85 $134.95 $131.85 $133.29 1 396 553
Feb 25, 2019 $130.50 $133.37 $130.50 $133.17 1 574 532
Feb 22, 2019 $127.93 $129.85 $126.86 $129.73 1 221 577
Feb 21, 2019 $129.63 $130.09 $126.30 $127.55 1 019 720
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT